We are working with world class researchers to select suitable genes for newborns in Taiwan and to develop the protocol from pre-test genetic counseling to post-test health care, aiming to provide a strong tool to enhance newborn health management for pediatricians and parents in Taiwan.
An expanded self-paid carrier screening that helps parents detect, compared to traditional carrier screening, a wider range of potential genetic disorder risks and genetic insights on lifelong health for their baby. We use our proprietary WES PLUS (WES + lcWGS) technology to achieve optimal cost-efficiency and accuracy.
An universal self-paid newborn sequencing report designed to provide early detection of actionable genetic disorder and genetic insights on lifelong health for the newborn. We use short read WGS technology for newborn and offer re-analyzing service to achieve better accuracy and excellent long-term care.
We offer our clients a research-based newborn sequencing report designed to deliver instant scientific evidence of genetic disorder for newborns, who go to neonatal intensive care unit (NICU) before the preemptive newborn sequencing report is delivered, helping the pediatricians make informed decisions. We will use rapid-WGS technology to achieve 72 hours report delivery.
Many genetic conditions take time to show symptoms and are irreversible. Our newborn sequencing report screens for over 400 actionable conditions so you can detect health risks early and take proactive measures.
Wilson’s Disease is a genetic disorder that prevents the body from removing copper and can be a progressive form of liver failure. It is usually unknown until copper builds up in the liver, brain, or other organs and initiates symptoms, but easy to treat when identified early.
Fabry disease is a rare, inherited disorder caused by a deficiency in the enzyme alpha-galactosidase A, leading to a buildup of a fatty substance called globotriaosylceramide in the body’s tissues, particularly affecting the kidneys, heart, and blood vessels. Treatments can help manage symptoms and slow the progression of the disease.
Mucopolysaccharidoses are a group of rare, inherited lysosomal storage disorders where the body lacks enzymes needed to break down complex sugar molecules called glycosaminoglycans (GAGs). This leads to GAG accumulation in cells and tissues, causing various health problems and affecting multiple organ systems. Early diagnosis and treatment, ideally before the onset of significant symptoms, are essential for maximizing the benefits of these therapies.
